Exagen Operating Expenses Growth & History (XGN)

Exagen's operating expenses was $52.9M for fiscal 2025.

View full Exagen company overview

Exagen annual operating expenses history

Exagen annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$52.9M$6.1M+13.09%
20242024-12-31$46.7M−$28.6M−37.99%
20232023-12-31$75.4M−$16.2M−17.71%
20222022-12-31$91.6M$19.2M+26.60%
20212021-12-31$72.4M$15.2M+26.60%
20202020-12-31$57.2M$7.5M+15.04%
20192019-12-31$49.7M$12.4M+33.14%
20182018-12-31$37.3M

Exagen operating expenses trends

Over the last five fiscal years, Exagen's operating expenses decreased from $57.2M to $52.9M, a change of −$4.3M. The latest reported quarter, Q2 2026, shows $13.9M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Exagen source filings ↗

Community posts

It’s quiet here.

No posts about XGN yet. Start the conversation.

Write the first post